Cystic fibrosis trials in Italy
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
- Where
- Milan
- Age
- 18 years and over
- People
- 64 worldwide
- Run by
- SpliSense Ltd.
See details and how to joinNCT06429176 - Phase 2Taking peopleA Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
- Where
- Milan, Monza, Palermo, Pavia, Rozzano
- Age
- 18 years to 80 years
- People
- 300 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07720375 · EU 2026-525524-18-00 - Phase 2Taking peopleEarly Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.
- Where
- Verona
- Age
- 18 years to 64 years
- People
- 35
- Run by
- Azienda Ospedaliera Universitaria Integrata Verona
See details and how to joinNCT07289035 · EU 2024-519657-11-00 - Phase 2Taking peopleA Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
- Where
- Bologna, Catania, Genoa, Monza, Pavia, Reggio Emilia, Rome, Rozzano
- Age
- 18 years to 80 years
- People
- 284 worldwide
- Run by
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
See details and how to joinNCT06559150 · EU 2024-514845-12-00 - No phaseTaking peopleA Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders
- Where
- Catania, Genova, Milan
- Age
- 28 days to 65 years
- People
- 165
- Run by
- Istituto Giannina Gaslini
See details and how to joinNCT07889973 - Phase 2Taking peopleDose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Where
- Bergamo, Foggia, Milan, Modena, Monza, Pavia, Rozzano, Trieste
- Age
- 18 years to 85 years
- People
- 180 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07048262 · EU 2024-518821-13-00 - Phase 4Taking peoplePharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis
- Where
- Florence, Genoa, Milan, Trieste
- Age
- 6 years and over
- People
- 50
- Run by
- Istituto Giannina Gaslini
See details and how to joinNCT07809867 · EU 2024-518785-28-00 - Phase 2Taking peopleA Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
- Where
- Catania, Florence, Messina, Milan, Roma, Rozzano
- Age
- 18 years to 85 years
- People
- 66 worldwide
- Run by
- Aimmune Nestlé Health Science US R&D, LLC
See details and how to joinNCT07559175 - Phase 2Taking peopleSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis
- Where
- Catania, Messina, Milan
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Splisense Ltd.
See details and how to join2024-511184-28-00 - Phase 2Not yet taking people in ItalySafety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis
- Where
- Florence, Milan, Rome, Verona
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Vertex Pharmaceuticals Inc.
See details and how to join2025-523400-72-00 - No phaseTaking peopleImpact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.
- Where
- Bari, Florence, Milan, Naples, Roma, Torino
- Age
- 2 years and over
- People
- 150
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT07363304 - Phase 2Taking peopleAn open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa) infections in cystic fibrosis patients
- Where
- Milan, Verona
- Age
- Up to 64 years
- People
- 12
- Run by
- Azienda Ospedaliera Universitaria Integrata Verona
See details and how to join2024-517820-21-00 - No phaseTaking peopleIdentification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
- Where
- Milan
- Age
- 18 years and over
- People
- 40
- Run by
- Ospedale San Raffaele
See details and how to joinNCT06413459